Global Newborn Screening for SMA and SCID Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Newborn Screening for SMA and SCID market size was valued at USD 133 million in 2023 and is forecast to a readjusted size of USD 276.3 million by 2030 with a CAGR of 11.0% during review period.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
The Global Info Research report includes an overview of the development of the Newborn Screening for SMA and SCID industry chain, the market status of SCID Screening (Instruments, Kits), SMA Screening (Instruments, Kits), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Newborn Screening for SMA and SCID.
Regionally, the report analyzes the Newborn Screening for SMA and SCID markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Newborn Screening for SMA and SCID market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Newborn Screening for SMA and SCID market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Newborn Screening for SMA and SCID industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Instruments, Kits).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Newborn Screening for SMA and SCID market.
Regional Analysis: The report involves examining the Newborn Screening for SMA and SCID market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Newborn Screening for SMA and SCID market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Newborn Screening for SMA and SCID:
Company Analysis: Report covers individual Newborn Screening for SMA and SCID players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Newborn Screening for SMA and SCID This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (SCID Screening, SMA Screening).
Technology Analysis: Report covers specific technologies relevant to Newborn Screening for SMA and SCID. It assesses the current state, advancements, and potential future developments in Newborn Screening for SMA and SCID areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Newborn Screening for SMA and SCID market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Newborn Screening for SMA and SCID market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Newborn Screening for SMA and SCID product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Newborn Screening for SMA and SCID, with revenue, gross margin and global market share of Newborn Screening for SMA and SCID from 2019 to 2024.
Chapter 3, the Newborn Screening for SMA and SCID competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Newborn Screening for SMA and SCID market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Screening for SMA and SCID.
Chapter 13, to describe Newborn Screening for SMA and SCID research findings and conclusion.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
The Global Info Research report includes an overview of the development of the Newborn Screening for SMA and SCID industry chain, the market status of SCID Screening (Instruments, Kits), SMA Screening (Instruments, Kits), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Newborn Screening for SMA and SCID.
Regionally, the report analyzes the Newborn Screening for SMA and SCID markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Newborn Screening for SMA and SCID market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Newborn Screening for SMA and SCID market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Newborn Screening for SMA and SCID industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Instruments, Kits).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Newborn Screening for SMA and SCID market.
Regional Analysis: The report involves examining the Newborn Screening for SMA and SCID market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Newborn Screening for SMA and SCID market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Newborn Screening for SMA and SCID:
Company Analysis: Report covers individual Newborn Screening for SMA and SCID players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Newborn Screening for SMA and SCID This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (SCID Screening, SMA Screening).
Technology Analysis: Report covers specific technologies relevant to Newborn Screening for SMA and SCID. It assesses the current state, advancements, and potential future developments in Newborn Screening for SMA and SCID areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Newborn Screening for SMA and SCID market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Newborn Screening for SMA and SCID market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Instruments
- Kits
- Software
- SCID Screening
- SMA Screening
- Perkinelmer
- Thermo Fisher
- ImmunoIVD
- Labsystems Diagnostics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Newborn Screening for SMA and SCID product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Newborn Screening for SMA and SCID, with revenue, gross margin and global market share of Newborn Screening for SMA and SCID from 2019 to 2024.
Chapter 3, the Newborn Screening for SMA and SCID competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Newborn Screening for SMA and SCID market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Screening for SMA and SCID.
Chapter 13, to describe Newborn Screening for SMA and SCID research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Newborn Screening for SMA and SCID
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Newborn Screening for SMA and SCID by Type
1.3.1 Overview: Global Newborn Screening for SMA and SCID Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Newborn Screening for SMA and SCID Consumption Value Market Share by Type in 2023
1.3.3 Instruments
1.3.4 Kits
1.3.5 Software
1.4 Global Newborn Screening for SMA and SCID Market by Application
1.4.1 Overview: Global Newborn Screening for SMA and SCID Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 SCID Screening
1.4.3 SMA Screening
1.5 Global Newborn Screening for SMA and SCID Market Size & Forecast
1.6 Global Newborn Screening for SMA and SCID Market Size and Forecast by Region
1.6.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Newborn Screening for SMA and SCID Market Size by Region, (2019-2030)
1.6.3 North America Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
1.6.4 Europe Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
1.6.6 South America Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Perkinelmer
2.1.1 Perkinelmer Details
2.1.2 Perkinelmer Major Business
2.1.3 Perkinelmer Newborn Screening for SMA and SCID Product and Solutions
2.1.4 Perkinelmer Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Perkinelmer Recent Developments and Future Plans
2.2 Thermo Fisher
2.2.1 Thermo Fisher Details
2.2.2 Thermo Fisher Major Business
2.2.3 Thermo Fisher Newborn Screening for SMA and SCID Product and Solutions
2.2.4 Thermo Fisher Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Thermo Fisher Recent Developments and Future Plans
2.3 ImmunoIVD
2.3.1 ImmunoIVD Details
2.3.2 ImmunoIVD Major Business
2.3.3 ImmunoIVD Newborn Screening for SMA and SCID Product and Solutions
2.3.4 ImmunoIVD Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 ImmunoIVD Recent Developments and Future Plans
2.4 Labsystems Diagnostics
2.4.1 Labsystems Diagnostics Details
2.4.2 Labsystems Diagnostics Major Business
2.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Product and Solutions
2.4.4 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Labsystems Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Newborn Screening for SMA and SCID Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Newborn Screening for SMA and SCID by Company Revenue
3.2.2 Top 3 Newborn Screening for SMA and SCID Players Market Share in 2023
3.2.3 Top 6 Newborn Screening for SMA and SCID Players Market Share in 2023
3.3 Newborn Screening for SMA and SCID Market: Overall Company Footprint Analysis
3.3.1 Newborn Screening for SMA and SCID Market: Region Footprint
3.3.2 Newborn Screening for SMA and SCID Market: Company Product Type Footprint
3.3.3 Newborn Screening for SMA and SCID Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Newborn Screening for SMA and SCID Consumption Value and Market Share by Type (2019-2024)
4.2 Global Newborn Screening for SMA and SCID Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2024)
5.2 Global Newborn Screening for SMA and SCID Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
6.2 North America Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
6.3 North America Newborn Screening for SMA and SCID Market Size by Country
6.3.1 North America Newborn Screening for SMA and SCID Consumption Value by Country (2019-2030)
6.3.2 United States Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
6.3.3 Canada Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
6.3.4 Mexico Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
7.2 Europe Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
7.3 Europe Newborn Screening for SMA and SCID Market Size by Country
7.3.1 Europe Newborn Screening for SMA and SCID Consumption Value by Country (2019-2030)
7.3.2 Germany Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7.3.3 France Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7.3.5 Russia Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7.3.6 Italy Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region
8.3.1 Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Region (2019-2030)
8.3.2 China Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.3 Japan Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.4 South Korea Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.5 India Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.7 Australia Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
9.2 South America Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
9.3 South America Newborn Screening for SMA and SCID Market Size by Country
9.3.1 South America Newborn Screening for SMA and SCID Consumption Value by Country (2019-2030)
9.3.2 Brazil Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
9.3.3 Argentina Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country
10.3.1 Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Country (2019-2030)
10.3.2 Turkey Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
10.3.4 UAE Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Newborn Screening for SMA and SCID Market Drivers
11.2 Newborn Screening for SMA and SCID Market Restraints
11.3 Newborn Screening for SMA and SCID Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Newborn Screening for SMA and SCID Industry Chain
12.2 Newborn Screening for SMA and SCID Upstream Analysis
12.3 Newborn Screening for SMA and SCID Midstream Analysis
12.4 Newborn Screening for SMA and SCID Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Newborn Screening for SMA and SCID
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Newborn Screening for SMA and SCID by Type
1.3.1 Overview: Global Newborn Screening for SMA and SCID Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Newborn Screening for SMA and SCID Consumption Value Market Share by Type in 2023
1.3.3 Instruments
1.3.4 Kits
1.3.5 Software
1.4 Global Newborn Screening for SMA and SCID Market by Application
1.4.1 Overview: Global Newborn Screening for SMA and SCID Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 SCID Screening
1.4.3 SMA Screening
1.5 Global Newborn Screening for SMA and SCID Market Size & Forecast
1.6 Global Newborn Screening for SMA and SCID Market Size and Forecast by Region
1.6.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Newborn Screening for SMA and SCID Market Size by Region, (2019-2030)
1.6.3 North America Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
1.6.4 Europe Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
1.6.6 South America Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Newborn Screening for SMA and SCID Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Perkinelmer
2.1.1 Perkinelmer Details
2.1.2 Perkinelmer Major Business
2.1.3 Perkinelmer Newborn Screening for SMA and SCID Product and Solutions
2.1.4 Perkinelmer Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Perkinelmer Recent Developments and Future Plans
2.2 Thermo Fisher
2.2.1 Thermo Fisher Details
2.2.2 Thermo Fisher Major Business
2.2.3 Thermo Fisher Newborn Screening for SMA and SCID Product and Solutions
2.2.4 Thermo Fisher Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Thermo Fisher Recent Developments and Future Plans
2.3 ImmunoIVD
2.3.1 ImmunoIVD Details
2.3.2 ImmunoIVD Major Business
2.3.3 ImmunoIVD Newborn Screening for SMA and SCID Product and Solutions
2.3.4 ImmunoIVD Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 ImmunoIVD Recent Developments and Future Plans
2.4 Labsystems Diagnostics
2.4.1 Labsystems Diagnostics Details
2.4.2 Labsystems Diagnostics Major Business
2.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Product and Solutions
2.4.4 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Labsystems Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Newborn Screening for SMA and SCID Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Newborn Screening for SMA and SCID by Company Revenue
3.2.2 Top 3 Newborn Screening for SMA and SCID Players Market Share in 2023
3.2.3 Top 6 Newborn Screening for SMA and SCID Players Market Share in 2023
3.3 Newborn Screening for SMA and SCID Market: Overall Company Footprint Analysis
3.3.1 Newborn Screening for SMA and SCID Market: Region Footprint
3.3.2 Newborn Screening for SMA and SCID Market: Company Product Type Footprint
3.3.3 Newborn Screening for SMA and SCID Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Newborn Screening for SMA and SCID Consumption Value and Market Share by Type (2019-2024)
4.2 Global Newborn Screening for SMA and SCID Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2024)
5.2 Global Newborn Screening for SMA and SCID Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
6.2 North America Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
6.3 North America Newborn Screening for SMA and SCID Market Size by Country
6.3.1 North America Newborn Screening for SMA and SCID Consumption Value by Country (2019-2030)
6.3.2 United States Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
6.3.3 Canada Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
6.3.4 Mexico Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
7.2 Europe Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
7.3 Europe Newborn Screening for SMA and SCID Market Size by Country
7.3.1 Europe Newborn Screening for SMA and SCID Consumption Value by Country (2019-2030)
7.3.2 Germany Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7.3.3 France Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7.3.5 Russia Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
7.3.6 Italy Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region
8.3.1 Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Region (2019-2030)
8.3.2 China Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.3 Japan Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.4 South Korea Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.5 India Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
8.3.7 Australia Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
9.2 South America Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
9.3 South America Newborn Screening for SMA and SCID Market Size by Country
9.3.1 South America Newborn Screening for SMA and SCID Consumption Value by Country (2019-2030)
9.3.2 Brazil Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
9.3.3 Argentina Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country
10.3.1 Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Country (2019-2030)
10.3.2 Turkey Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
10.3.4 UAE Newborn Screening for SMA and SCID Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Newborn Screening for SMA and SCID Market Drivers
11.2 Newborn Screening for SMA and SCID Market Restraints
11.3 Newborn Screening for SMA and SCID Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Newborn Screening for SMA and SCID Industry Chain
12.2 Newborn Screening for SMA and SCID Upstream Analysis
12.3 Newborn Screening for SMA and SCID Midstream Analysis
12.4 Newborn Screening for SMA and SCID Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Newborn Screening for SMA and SCID Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Newborn Screening for SMA and SCID Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Newborn Screening for SMA and SCID Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Newborn Screening for SMA and SCID Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Perkinelmer Company Information, Head Office, and Major Competitors
Table 6. Perkinelmer Major Business
Table 7. Perkinelmer Newborn Screening for SMA and SCID Product and Solutions
Table 8. Perkinelmer Newborn Screening for SMA and SCID Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Perkinelmer Recent Developments and Future Plans
Table 10. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Major Business
Table 12. Thermo Fisher Newborn Screening for SMA and SCID Product and Solutions
Table 13. Thermo Fisher Newborn Screening for SMA and SCID Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Thermo Fisher Recent Developments and Future Plans
Table 15. ImmunoIVD Company Information, Head Office, and Major Competitors
Table 16. ImmunoIVD Major Business
Table 17. ImmunoIVD Newborn Screening for SMA and SCID Product and Solutions
Table 18. ImmunoIVD Newborn Screening for SMA and SCID Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. ImmunoIVD Recent Developments and Future Plans
Table 20. Labsystems Diagnostics Company Information, Head Office, and Major Competitors
Table 21. Labsystems Diagnostics Major Business
Table 22. Labsystems Diagnostics Newborn Screening for SMA and SCID Product and Solutions
Table 23. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Labsystems Diagnostics Recent Developments and Future Plans
Table 25. Global Newborn Screening for SMA and SCID Revenue (USD Million) by Players (2019-2024)
Table 26. Global Newborn Screening for SMA and SCID Revenue Share by Players (2019-2024)
Table 27. Breakdown of Newborn Screening for SMA and SCID by Company Type (Tier 1, Tier 2, and Tier 3)
Table 28. Market Position of Players in Newborn Screening for SMA and SCID, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 29. Head Office of Key Newborn Screening for SMA and SCID Players
Table 30. Newborn Screening for SMA and SCID Market: Company Product Type Footprint
Table 31. Newborn Screening for SMA and SCID Market: Company Product Application Footprint
Table 32. Newborn Screening for SMA and SCID New Market Entrants and Barriers to Market Entry
Table 33. Newborn Screening for SMA and SCID Mergers, Acquisition, Agreements, and Collaborations
Table 34. Global Newborn Screening for SMA and SCID Consumption Value (USD Million) by Type (2019-2024)
Table 35. Global Newborn Screening for SMA and SCID Consumption Value Share by Type (2019-2024)
Table 36. Global Newborn Screening for SMA and SCID Consumption Value Forecast by Type (2025-2030)
Table 37. Global Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024)
Table 38. Global Newborn Screening for SMA and SCID Consumption Value Forecast by Application (2025-2030)
Table 39. North America Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 40. North America Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 41. North America Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 42. North America Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 43. North America Newborn Screening for SMA and SCID Consumption Value by Country (2019-2024) & (USD Million)
Table 44. North America Newborn Screening for SMA and SCID Consumption Value by Country (2025-2030) & (USD Million)
Table 45. Europe Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Europe Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Europe Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 48. Europe Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 49. Europe Newborn Screening for SMA and SCID Consumption Value by Country (2019-2024) & (USD Million)
Table 50. Europe Newborn Screening for SMA and SCID Consumption Value by Country (2025-2030) & (USD Million)
Table 51. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 52. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 53. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 54. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 55. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Region (2019-2024) & (USD Million)
Table 56. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Region (2025-2030) & (USD Million)
Table 57. South America Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 58. South America Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 59. South America Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 60. South America Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 61. South America Newborn Screening for SMA and SCID Consumption Value by Country (2019-2024) & (USD Million)
Table 62. South America Newborn Screening for SMA and SCID Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 64. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 65. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 66. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 67. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Country (2019-2024) & (USD Million)
Table 68. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Country (2025-2030) & (USD Million)
Table 69. Newborn Screening for SMA and SCID Raw Material
Table 70. Key Suppliers of Newborn Screening for SMA and SCID Raw Materials
Table 1. Global Newborn Screening for SMA and SCID Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Newborn Screening for SMA and SCID Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Newborn Screening for SMA and SCID Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Newborn Screening for SMA and SCID Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Perkinelmer Company Information, Head Office, and Major Competitors
Table 6. Perkinelmer Major Business
Table 7. Perkinelmer Newborn Screening for SMA and SCID Product and Solutions
Table 8. Perkinelmer Newborn Screening for SMA and SCID Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Perkinelmer Recent Developments and Future Plans
Table 10. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Major Business
Table 12. Thermo Fisher Newborn Screening for SMA and SCID Product and Solutions
Table 13. Thermo Fisher Newborn Screening for SMA and SCID Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Thermo Fisher Recent Developments and Future Plans
Table 15. ImmunoIVD Company Information, Head Office, and Major Competitors
Table 16. ImmunoIVD Major Business
Table 17. ImmunoIVD Newborn Screening for SMA and SCID Product and Solutions
Table 18. ImmunoIVD Newborn Screening for SMA and SCID Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. ImmunoIVD Recent Developments and Future Plans
Table 20. Labsystems Diagnostics Company Information, Head Office, and Major Competitors
Table 21. Labsystems Diagnostics Major Business
Table 22. Labsystems Diagnostics Newborn Screening for SMA and SCID Product and Solutions
Table 23. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Labsystems Diagnostics Recent Developments and Future Plans
Table 25. Global Newborn Screening for SMA and SCID Revenue (USD Million) by Players (2019-2024)
Table 26. Global Newborn Screening for SMA and SCID Revenue Share by Players (2019-2024)
Table 27. Breakdown of Newborn Screening for SMA and SCID by Company Type (Tier 1, Tier 2, and Tier 3)
Table 28. Market Position of Players in Newborn Screening for SMA and SCID, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 29. Head Office of Key Newborn Screening for SMA and SCID Players
Table 30. Newborn Screening for SMA and SCID Market: Company Product Type Footprint
Table 31. Newborn Screening for SMA and SCID Market: Company Product Application Footprint
Table 32. Newborn Screening for SMA and SCID New Market Entrants and Barriers to Market Entry
Table 33. Newborn Screening for SMA and SCID Mergers, Acquisition, Agreements, and Collaborations
Table 34. Global Newborn Screening for SMA and SCID Consumption Value (USD Million) by Type (2019-2024)
Table 35. Global Newborn Screening for SMA and SCID Consumption Value Share by Type (2019-2024)
Table 36. Global Newborn Screening for SMA and SCID Consumption Value Forecast by Type (2025-2030)
Table 37. Global Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024)
Table 38. Global Newborn Screening for SMA and SCID Consumption Value Forecast by Application (2025-2030)
Table 39. North America Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 40. North America Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 41. North America Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 42. North America Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 43. North America Newborn Screening for SMA and SCID Consumption Value by Country (2019-2024) & (USD Million)
Table 44. North America Newborn Screening for SMA and SCID Consumption Value by Country (2025-2030) & (USD Million)
Table 45. Europe Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Europe Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Europe Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 48. Europe Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 49. Europe Newborn Screening for SMA and SCID Consumption Value by Country (2019-2024) & (USD Million)
Table 50. Europe Newborn Screening for SMA and SCID Consumption Value by Country (2025-2030) & (USD Million)
Table 51. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 52. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 53. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 54. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 55. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Region (2019-2024) & (USD Million)
Table 56. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Region (2025-2030) & (USD Million)
Table 57. South America Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 58. South America Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 59. South America Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 60. South America Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 61. South America Newborn Screening for SMA and SCID Consumption Value by Country (2019-2024) & (USD Million)
Table 62. South America Newborn Screening for SMA and SCID Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Type (2019-2024) & (USD Million)
Table 64. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Type (2025-2030) & (USD Million)
Table 65. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Application (2019-2024) & (USD Million)
Table 66. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Application (2025-2030) & (USD Million)
Table 67. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Country (2019-2024) & (USD Million)
Table 68. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Country (2025-2030) & (USD Million)
Table 69. Newborn Screening for SMA and SCID Raw Material
Table 70. Key Suppliers of Newborn Screening for SMA and SCID Raw Materials
LIST OF FIGURES
Figure 1. Newborn Screening for SMA and SCID Picture
Figure 2. Global Newborn Screening for SMA and SCID Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Newborn Screening for SMA and SCID Consumption Value Market Share by Type in 2023
Figure 4. Instruments
Figure 5. Kits
Figure 6. Software
Figure 7. Global Newborn Screening for SMA and SCID Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Newborn Screening for SMA and SCID Consumption Value Market Share by Application in 2023
Figure 9. SCID Screening Picture
Figure 10. SMA Screening Picture
Figure 11. Global Newborn Screening for SMA and SCID Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Newborn Screening for SMA and SCID Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Newborn Screening for SMA and SCID Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Newborn Screening for SMA and SCID Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Newborn Screening for SMA and SCID Consumption Value Market Share by Region in 2023
Figure 16. North America Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Newborn Screening for SMA and SCID Revenue Share by Players in 2023
Figure 22. Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Newborn Screening for SMA and SCID Market Share in 2023
Figure 24. Global Top 6 Players Newborn Screening for SMA and SCID Market Share in 2023
Figure 25. Global Newborn Screening for SMA and SCID Consumption Value Share by Type (2019-2024)
Figure 26. Global Newborn Screening for SMA and SCID Market Share Forecast by Type (2025-2030)
Figure 27. Global Newborn Screening for SMA and SCID Consumption Value Share by Application (2019-2024)
Figure 28. Global Newborn Screening for SMA and SCID Market Share Forecast by Application (2025-2030)
Figure 29. North America Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Newborn Screening for SMA and SCID Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Newborn Screening for SMA and SCID Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 39. France Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value Market Share by Region (2019-2030)
Figure 46. China Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 49. India Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Newborn Screening for SMA and SCID Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Newborn Screening for SMA and SCID Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 63. Newborn Screening for SMA and SCID Market Drivers
Figure 64. Newborn Screening for SMA and SCID Market Restraints
Figure 65. Newborn Screening for SMA and SCID Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Newborn Screening for SMA and SCID in 2023
Figure 68. Manufacturing Process Analysis of Newborn Screening for SMA and SCID
Figure 69. Newborn Screening for SMA and SCID Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Newborn Screening for SMA and SCID Picture
Figure 2. Global Newborn Screening for SMA and SCID Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Newborn Screening for SMA and SCID Consumption Value Market Share by Type in 2023
Figure 4. Instruments
Figure 5. Kits
Figure 6. Software
Figure 7. Global Newborn Screening for SMA and SCID Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Newborn Screening for SMA and SCID Consumption Value Market Share by Application in 2023
Figure 9. SCID Screening Picture
Figure 10. SMA Screening Picture
Figure 11. Global Newborn Screening for SMA and SCID Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Newborn Screening for SMA and SCID Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Newborn Screening for SMA and SCID Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Newborn Screening for SMA and SCID Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Newborn Screening for SMA and SCID Consumption Value Market Share by Region in 2023
Figure 16. North America Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Newborn Screening for SMA and SCID Revenue Share by Players in 2023
Figure 22. Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Newborn Screening for SMA and SCID Market Share in 2023
Figure 24. Global Top 6 Players Newborn Screening for SMA and SCID Market Share in 2023
Figure 25. Global Newborn Screening for SMA and SCID Consumption Value Share by Type (2019-2024)
Figure 26. Global Newborn Screening for SMA and SCID Market Share Forecast by Type (2025-2030)
Figure 27. Global Newborn Screening for SMA and SCID Consumption Value Share by Application (2019-2024)
Figure 28. Global Newborn Screening for SMA and SCID Market Share Forecast by Application (2025-2030)
Figure 29. North America Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Newborn Screening for SMA and SCID Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Newborn Screening for SMA and SCID Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 39. France Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Newborn Screening for SMA and SCID Consumption Value Market Share by Region (2019-2030)
Figure 46. China Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 49. India Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Newborn Screening for SMA and SCID Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Newborn Screening for SMA and SCID Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Newborn Screening for SMA and SCID Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Newborn Screening for SMA and SCID Consumption Value (2019-2030) & (USD Million)
Figure 63. Newborn Screening for SMA and SCID Market Drivers
Figure 64. Newborn Screening for SMA and SCID Market Restraints
Figure 65. Newborn Screening for SMA and SCID Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Newborn Screening for SMA and SCID in 2023
Figure 68. Manufacturing Process Analysis of Newborn Screening for SMA and SCID
Figure 69. Newborn Screening for SMA and SCID Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
